# Silicon-28

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/silicon-28
Canonical HTML page: https://getbiobrief.com/entity/silicon-28

## Timeline

- **2026**: QLE Spin-off Completion — Formal separation of the Quantum Leap Energy subsidiary into a standalone entity.
- **2026**: Commercial Ramp-up — Full-scale commercial production across medical and industrial isotope lines.
- **2025-Q4**: Silicon-28 Shipments — Initial shipments of high-purity Silicon-28 to semiconductor partners.

## Recent coverage (1 stories)

### ASP Isotopes Targets 2026 Commercial Pivot with Silicon-28 and QLE Spin-Off
2026-02-26 12:21:14 · Sentiment: Positive · Impact: 6/10 · Sources: 2

ASP Isotopes CEO Paul Mann announced a 2026 commercialization ramp-up, highlighted by the upcoming shipment of Silicon-28 and the strategic spin-off of its Quantum Leap Energy (QLE) subsidiary. The move signals a transition from a pre-commercial advanced materials firm to a revenue-generating producer of medical and industrial isotopes.
Full story: https://getbiobrief.com/story/asp-isotopes-2026-commercial-ramp-qle-spinoff

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.